Elevance Health raises 2026 outlook as Elevance Health stock trades at EUR 385.35

Published on 10/22/2026 at 11:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Elevance Health raises its 2026 outlook. Elevance Health stock costs EUR 385.35 on October 22, 2026; revenue rose 0.7 percent.

Outlook and shareholder returns

Third-quarter operating revenue reached USD 50.4 billion on October 21, 2026.
Elevance Health declared a USD 1.72 quarterly dividend on October 20, 2026.
Elevance Health stock trades at EUR 385.35 at 11:12 a.m. CEST at Lang & Schwarz on October 22, 2026.
The dividend is payable on December 18, 2026.

Modernes Krankenhaus-Campus mit Glasfassade und Patienten im Eingangsbereich — Elevance Health Krankenversicherungs-Campus US2855211023 zeigt modernen Gebäudeeingang mit weitläufiger Grünanlage unter blauem Himmel, Illustration mit AI erstellt.

Elevance Health (ISIN US0367521038) raised its 2026 earnings outlook after reporting third-quarter operating revenue of USD 50.4 billion, up 0.7 percent from the third quarter of 2025. The company released the figures on October 21, 2026, according to Elevance Health. Adjusted diluted earnings per share reached USD 6.99, while full-year adjusted diluted earnings per share guidance rose to at least USD 29.00.

Raised guidance meets operating pressure

The guidance increase gives investors a stronger earnings framework for 2026, but the quarter also shows why medical-cost trends remain central. The benefit expense ratio improved to 90.6 percent in the third quarter, down from 91.3 percent a year earlier, while medical membership fell by 487,000 to approximately 44.9 million as of September 30, 2026.

Reuters reported on October 21, 2026, that lower medical costs helped the insurer raise its adjusted profit forecast. The company also lifted full-year operating cash flow guidance to at least USD 6.5 billion.

Three dated steps shape the story

On October 5, 2026, Elevance Health scheduled its third-quarter results call for October 21, according to StockTitan. On October 20, the company declared a fourth-quarter dividend of USD 1.72 per share. On October 21, it reported USD 50.4 billion in third-quarter operating revenue and raised adjusted earnings guidance to at least USD 29.00.

What dates matter for shareholders?

The fourth-quarter dividend is payable on December 18, 2026, to shareholders of record at the close of business on December 4, 2026, according to the Elevance Health release. Those dates provide the next concrete shareholder timetable after the earnings announcement. The dividend amount is unchanged in the release at USD 1.72 per share.

Stock price and investor view

For investors, the central tension is visible in the combination of stronger guidance and lower membership. Carelon operating revenue rose to USD 19.3 billion in the third quarter, an increase of 5 percent from the prior-year quarter, while Carelon operating gain increased 17 percent year over year. The result gives the services business a measurable role in offsetting pressure in the health benefits operations.

Elevance Health stock was trading at EUR 385.35 at Lang & Schwarz on October 22, 2026 at 11:12 a.m. CEST.

The further course of trading is shown by the continuously updated real-time quote of Elevance Health stock.